Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Baugh, JN; van Zanten, SV; Fiocco, M; Colditz, N; Hoffmann, M; Janssens, GO; Valentini, C; Hargrave, D; Wiese, M; von Bueren, AO; Karremann, M; Perwein, T; Nussbaumer, G; Benesch, M; Sturm, D; Gielen, GH; Krause, M; Eyrich, M; Hoving, EW; Bison, B; van Vuurden, DG; Kramm, CM.
Treatment-related survival patterns in diffuse intrinsic pontine glioma using a historical cohort: A report from the European Society for Pediatric Oncology DIPG/DMG Registry
NEURO-ONCOL ADV. 2024; 6(1): vdae155
Doi: 10.1093/noajnl/vdae155
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Benesch Martin
- Nussbaumer Gunther
- Perwein Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Diffuse intrinsic pontine glioma (DIPG) is a very aggressive brain tumor that affects children. Different treatment approaches have been tried. In this study, the authors wanted to see how the different treatments affect how long children with DIPG live. To do this, they combined data from 409 children with DIPG. They found that children who only had radiation therapy lived for 10.4 months after their diagnosis, while those treated with both radiation and chemotherapy lived for 11.7 months. Children who did not have any treatment lived for 3 months. After the tumor got worse, children who did not receive any further treatment lived for 2.2 more months, while those treated with chemotherapy or additional radiation lived 6.6 months longer.
- Find related publications in this database (Keywords)
- diffuse intrinsic pontine glioma
- diffuse midline glioma
- DIPG
- historical control
- registry